Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled Exploratory Trial to Investigate Efficacy and Safety of IGN-ES001 in Patients With Chronic Widespread Pain With or Without Fibromyalgia

NCT03058224 is registered in ClinicalTrials.gov with IgNova GmbH as lead sponsor.

NCT NCT03058224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03058224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled Exploratory Trial to Investigate Efficacy and Safety of IGN-ES001 in Patients With Chronic Widespread Pain With or Without Fibromyalgia
Lead sponsor
IgNova GmbH
Phase
Not applicable
Overall status
Completed
Start date
February 16, 2017
Completion date
December 8, 2017
Enrollment
230 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

chronic widespread pain, fibromyalgia